An interventional study of Simulation of Virtual Reality in Breastfeeding Expectations and Breastfeeding Avoidance, sponsored by Ebru Ertas. Not yet recruiting. Open to female participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by Ebru Ertas · Not applicable, Interventional, and Supportive care
This randomized controlled trial aims to examine the effect of a virtual reality breastfeeding experience on breastfeeding expectations during pregnancy and breastfeeding avoidance after childbirth. Pregnant women will be randomly assigned to a group that receives a virtual reality breastfeeding experience or a control group. Breastfeeding expectations will be assessed, and breastfeeding avoidance will be evaluated after childbirth. The study will investigate whether experiencing a breastfeeding scenario in a virtual environment can help women develop more positive expectations about breastfeeding and reduce breastfeeding avoidance after birth. The findings may contribute to the development of innovative educational approaches to support breastfeeding preparation during pregnancy.
This randomized controlled trial will investigate whether a virtual reality (VR) breastfeeding experience during pregnancy affects breastfeeding expectations and breastfeeding avoidance after childbirth. Participants will be randomly assigned to a VR intervention group or a control group. Breastfeeding expectations will be assessed during pregnancy, and breastfeeding avoidance will be evaluated after childbirth. The findings may help determine whether VR can be a useful educational approach for preparing women for breastfeeding.
1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.
This study's planned enrollment of 50 is below the median of 100 across 844 interventional studies indexed under Breast Feeding.
Browse Breast Feeding studies →This is the only study on the registry with Ebru Ertas as lead sponsor.
Counted across the registry records on this site, refreshed daily.
The criteria were revised on the registry on Nov 2, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will complete the Personal Information Form and Breastfeeding Expectations Scale at 36 weeks of gestation, receive two virtual reality breastfeeding simulation sessions at 36 and 37 weeks, and complete the Breastfeeding Expectations Scale again at 38 weeks of gestation and the Breastfeeding Avoidance Scale one month after childbirth.
Other: Simulation of Virtual Reality
Participants will receive routine antenatal care, complete the Personal Information Form and Breastfeeding Expectations Scale at 36 and 38 weeks of gestation, and complete the Breastfeeding Avoidance Scale one month after childbirth.
Participants will receive usual care and two virtual reality breastfeeding simulation sessions at 36 and 37 weeks of gestation. The sessions will be conducted using a virtual reality headset in a quiet, comfortable environment, with participants seated in a comfortable chair. The intervention is designed to provide an immersive breastfeeding experience before childbirth.
Change in Breastfeeding Expectations Score
Breastfeeding expectations will be assessed using the Breastfeeding Expectations Scale at 36 weeks of gestation (baseline) and 38 weeks of gestation (follow-up). The change in scale scores from baseline to follow-up will be compared between the virtual reality intervention group and the control group. The scale consists of 12 items and follows a 5-point Likert format. The minimum score that can be obtained on the scale is 12, and the maximum score is 60. Lower scores on the scale indicate higher positive expectations regarding the breastfeeding experience.
Time frame: From 36 weeks to 38 weeks of gestation
Breastfeeding Avoidance Score at 1 Month Postpartum
Breastfeeding avoidance will be assessed using the Breastfeeding Avoidance Scale one month after childbirth. Scores will be compared between the virtual reality intervention group and the control group to evaluate the effect of the intervention on postpartum breastfeeding avoidance. The scale consists of 18 items and follows a 5-point Likert format. The minimum score that can be obtained on the scale is 18, and the maximum score is 90. As the score on the scale increases, the behavior of avoiding breastfeeding also increases.
Time frame: 1 month after childbirth
No study locations are listed for this record.
Plan to share: Yes — De-identified individual participant data collected during the study, including data relevant to the study outcomes, may be shared with qualified researchers upon reasonable request, subject to ethical approval, applicable data protection regulations, and approval by the responsible research team. The study protocol and statistical analysis plan may also be shared where appropriate.
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Dec 2027, 12 months later.
Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 12 months is close to that.
Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.